X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

July 10, 2019

Intended Use and Packaging Risks for Compounding Pharmacies (503Bs)

In 2015, the FDA shed light on a problematic practice within the healthcare industry involving improper, off-label use of syringes as closed container storage systems for compounded or repackaged drugs. The incidents cited revealed that interaction with rubber plungers in syringes that were not cleared for the purpose of closed container storage resulted in the loss of potency of several drugs when administration was delayed.<sup>1</sup>
Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

Previous Posts
FluroTec Barrier Film Coating

January 29, 2019

Effective Drug Protection for Plungers in a Prefillable Syringe System

Christa Jansen-Otten

Christa Jansen-Otten

Director, Product Mgmt, PFS & Delivery

Daikyo Crystal Zentih Leur Lock Syringe

May 01, 2018

Addressing the Complexities of Ophthalmic Drug Delivery

Susan Dounce

Susan Dounce

Principal SME, Prefilled Syringes, Crystal Zenith, Combination Products

NovaPure 1-3 mL and 1 mL plungers

September 28, 2017

Controlling Particle Load in NovaPure® Elastomer Components

Page McAndrew

Page McAndrew

Director, Scientific Communications, Scientific Affairs & TCS

Daikyo Crystal Zenith Syringe Systems

September 25, 2017

When Silicone Oil Is Not an Option

Birgit Mueller

Dr. Birgit Müller-Chorus

Principal Technical Subject Matter Expert PFS, TCS

NovaPure 1 mL and 1-3 mL plungers

February 06, 2017

NovaPure® Plungers for Biologic Applications

Christa Jansen-Otten

Christa Jansen-Otten, Director, Product Management

Petra Huhn, Manager, TCS Europe

Load more